1. Signaling Pathways
  2. Cell Cycle/DNA Damage
    Epigenetics
  3. Sirtuin

Sirtuin

Sirtuin

Sirtuin (Sir2 proteins) are a class of proteins that possess either mono-ADP-ribosyltransferase, or deacylase activity, including deacetylase, desuccinylase, demalonylase, demyristoylase and depalmitoylase activity. Sirtuins regulate important biological pathways in bacteria, archaeaand eukaryotes. Sirtuins have been implicated in influencing a wide range of cellular processes like aging, transcription, apoptosis, inflammation and stress resistance, as well as energy efficiency and alertness during low-calorie situations. Sirtuins can also control circadian clocks and mitochondrial biogenesis.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-B0150
    Nicotinamide
    Inhibitor 99.99%
    Nicotinamide is a form of vitamin B3 or niacin. Nicotinamide Hydrochloride inhibits SIRT2 activity (IC50: 2 μM). Nicotinamide also inhibits SIRT1. Nicotinamide increases cellular NAD+, ATP, ROS levels. Nicotinamide inhibits tumor growth and improves survival. Nicotinamide also has anti-HBV activity.
    Nicotinamide
  • HY-16561
    Resveratrol
    Activator 99.94%
    Resveratrol (trans-Resveratrol; SRT501), a natural polyphenolic phytoalexin that possesses anti-oxidant, anti-inflammatory, cardioprotective, and anti-cancer properties. Resveratrol (SRT 501) has a wide spectrum of targets including mTOR, JAK, β-amyloid, Adenylyl cyclase, IKKβ, DNA polymerase. Resveratrol also is a specific SIRT1 activator. Resveratrol is a potent pregnane X receptor (PXR) inhibitor. Resveratrol is an Nrf2 activator, ameliorates aging-related progressive renal injury in mice model. Resveratrol increases production of NO in endothelial cells.
    Resveratrol
  • HY-15452
    Selisistat
    Inhibitor 99.87%
    Selisistat (EX-527) is a potent and selective SirT1 (Sir2 in Drosophila melanogaster) inhibitor with an IC50 of 123 nM for SirT1. Selisistat alleviates pathology in multiple animal and cell models of Huntington's disease.
    Selisistat
  • HY-123033A
    Nicotinamide riboside chloride
    Activator 99.90%
    Nicotinamide riboside Chloride, an orally active NAD+ precursor, increases NAD+ levels and activates SIRT1 and SIRT3. Nicotinamide riboside Chloride is a source of vitamin B3 (niacin) and enhances oxidative metabolism, protection against high fat diet-induced metabolic abnormalities. Nicotinamide riboside Chloride reduces cognitive deterioration in a transgenic mouse model of Alzheimer’s disease.
    Nicotinamide riboside chloride
  • HY-108331
    3-TYP
    Inhibitor 99.96%
    3-TYP is an inhibitor of SIRT3 (IC50of 38 μM) and an inhibitor of Methionine Adenosyltransferase (MAT) 2 and Indoleamine 2,3-Dioxygenase (IDO). There may be many off-target sites for 3-TYP that need to be examined, such as NAD-dependent enzymes, including dehydrogenases.
    3-TYP
  • HY-169934
    SIRT1-IN-4
    Inhibitor
    SIRT1-IN-4 (Compound 8c) is a SIRT1 inhibitor, with an IC50 of 10.04 μM. SIRT1-IN-4 can be used for the research of cancer.
    SIRT1-IN-4
  • HY-173463
    Sirtuin modulator 8
    Modulator
    Sirtuin modulator 8 is a sirtuin modulator that can activate Sirtuin activity. Sirtuin modulator 8 significantly downregulates the expression of monocyte chemoattractant protein-1 (MCP-1) and upregulates the expression of fibroblast growth factor 21 (FGF21). Sirtuin modulator 8 regulates the expression of inflammation- and metabolism-related genes, showing potential for studying metabolic diseases (such as diabetes, obesity) and inflammatory diseases.
    Sirtuin modulator 8
  • HY-172204
    SIRT-IN-7
    Inhibitor
    SIRT-IN-7 (Compound 7ba) is a SIRT inhibitor. SIRT-IN-7 can inhibit the expression of SIRT1, SIRT2, and SIRT3, and increase the acetylation and activation of p53. SIRT-IN-7 can inhibit the proliferation, and induce apoptosis and autophagy of breast cancer cells. SIRT-IN-7 has anti-tumor activity.
    SIRT-IN-7
  • HY-N0182
    Fisetin
    Activator 99.99%
    Fisetin is a natural flavonol found in many fruits and vegetables with various benefits, such as antioxidant, anticancer, neuroprotection effects.
    Fisetin
  • HY-B0879A
    Suramin sodium salt
    Inhibitor 99.48%
    Suramin sodium salt (Suramin hexasodium salt) is a reversible and competitive protein-tyrosine phosphatases (PTPases) inhibitor. Suramin sodium salt is a potent inhibitor of sirtuins: SirT1 (IC50=297 nM), SirT2 (IC50=1.15 μM), and SirT5 (IC50=22 μM). Suramin sodium salt is a competitive inhibitor of reverse transcriptase (DNA topoisomerase II: IC50=5 μM). Suramin sodium salt is a potent SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) inhibitor. Suramin sodium salt efficiently inhibits IP5K and is an antiparasitic, anti-neoplastic and anti-angiogenic agent.
    Suramin sodium salt
  • HY-10532
    SRT 1720
    Activator 99.90%
    SRT 1720 is a selective activator of human SIRT1 with an EC1.5 of 0.16 μM, and shows less potent activities for SIRT2 and SIRT3 with EC1.5s of 37 μM and > 300 μM, respectively.
    SRT 1720
  • HY-107454
    OSS_128167
    Inhibitor 98.63%
    OSS_128167 is a potent selective sirtuin 6 (SIRT6) inhibitor with IC50s of 89 μM, 1578 μM and 751 μM for SIRT6, SIRT1 and SIRT2, respectively. OSS_128167 has anti-HBV activity that inhibits HBV transcription and replication. OSS_128167 has anti-cancer, anti-inflammation and anti-viral effects.
    OSS_128167
  • HY-100578
    AGK2
    Inhibitor 99.62%
    AGK2 is a selective SIRT2 inhibitor with an IC50 of 3.5 μM. AGK2 inhibits SIRT1 and SIRT3 with IC50s of 30 and 91 μM, respectively.
    AGK2
  • HY-15262
    SRT 2104
    Activator 99.00%
    SRT 2104 is a first-in-class, highly selective and brain-permeable activator of the NAD+ dependent deacetylase Sirt1, increases Sirt1 protein, but shows no effect on Sirt1 mRNA. Used in the research of diabetes mellitus and Huntington’s disease.
    SRT 2104
  • HY-112587
    MC3482
    Inhibitor 99.22%
    MC3482 is a specific sirtuin5 (SIRT5) inhibitor.
    MC3482
  • HY-13515
    Sirtinol
    Inhibitor ≥98.0%
    Sirtinol is a sirtuin (SIRT) inhibitor, with IC50s of 48 μM, 57.7 μM and 131 μM for ySir2, hSIRT2 and hSIRT2, respectively.
    Sirtinol
  • HY-15145
    SRT 1720 monohydrochloride
    Activator 99.92%
    SRT 1720 monohydrochloride is a selective and orally active activator of SIRT1 with an EC50 of 0.10 μM, and shows less potent activities on SIRT2 and SIRT3.
    SRT 1720 monohydrochloride
  • HY-115453
    UBCS039
    Activator 99.06%
    UBCS039 is the first synthetic, specific Sirtuin 6 (SIRT6) activator, inducing autophagy in human tumor cells, with an EC50 of 38 μM.
    UBCS039
  • HY-135899
    SIRT7 inhibitor 97491
    Inhibitor 98.81%
    SIRT7 inhibitor 97491, a potent SIRT7 inhibitor with an IC50 of 325 nM, reduces deacetylase activity of SIRT7 in a dose-dependent manner. SIRT7 inhibitor 97491 prevents tumor progression by increasing p53 stability through acetylation at K373/382. SIRT7 inhibitor 97491 promotes apoptosis through caspase pathway..
    SIRT7 inhibitor 97491
  • HY-101278
    Thiomyristoyl
    Inhibitor 99.74%
    Thiomyristoyl is a potent and specific SIRT2 inhibitor with an IC50 of 28 nM.
    Thiomyristoyl
Cat. No. Product Name / Synonyms Application Reactivity

Sirtuin

SIRT1

SIRT2

SIRT3

SIRT6

SIRT5

SIRT7

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

Sirtuin Inhibitors, Activators & Modulators
Product NameSirtuinSIRT1SIRT2SIRT3SIRT6SIRT5SIRT7Purity    
Nicotinamide 
SIRT1, IC50: 50-180 μM
SIRT2, EC50: 2 μM
    99.99%
Nicotinamide riboside chloride 
SIRT1
 
SIRT3
   99.90%
3-TYP   
SIRT3, IC50: 38 μM
   99.96%
SIRT1-IN-4 
SIRT1, IC50: 10.04 μM
     
Suramin sodium salt 
SIRT1, IC50: 297 nM
SIRT2, IC50: 1.15 μM
  
SIRT5, IC50: 22 μM
 99.48%
SRT 1720 
SIRT1, EC1.5: 0.16 μM
SIRT2, EC1.5: 37 μM
    99.90%
OSS_128167 
SIRT1, IC50: 1578 μM
SIRT2, IC50: 751 μM
 
SIRT6, IC50: 89 μM
  98.63%
AGK2 
SIRT1, IC50: 30 μM
SIRT2, IC50: 3.5 μM
SIRT3, IC50: 91 μM
   99.62%
SRT 2104 
SIRT1
     99.00%
Sirtinol 
ySir2, IC50: 48 μM
hSIRT1, IC50: 131 μM
hSIRT2, IC50: 57.7 μM
    ≥98.0%
SRT 1720 monohydrochloride 
SIRT1, EC1.5: 0.16 μM
SIRT1, EC50: 0.10 μM
SIRT2, EC1.5: 37 μM
    99.92%
UBCS039    
SIRT6, EC50: 38 μM
  99.06%
SIRT7 inhibitor 97491      
SIRT7, IC50: 325 nM
98.81%
Thiomyristoyl 
SIRT1, IC50: 98 μM
SIRT2, IC50: 28 nM
    99.74%
Resveratrol (Standard)
Sirtuin
      99.73%
SRT 1460 
SIRT1, EC1.5: 2.9 μM
     98.16%
SirReal2  
SIRT2, IC50: 140 nM
    ≥99.0%
Cambinol 
SIRT1, IC50: 56 μM
SIRT2, IC50: 59 μM
    99.89%
AK-7  
SIRT2, IC50: 15.5 μM
    99.63%
Ganoderic acid D   
SIRT3
   99.40%
SIRT6 activator 12q    
SIRT6, EC1.5: 0.58 μM
  98.01%
SRT 1720 dihydrochloride 
SIRT1, EC50: 0.10 μM
     99.13%
Agrimol B 
SIRT1
     99.75%
Tenovin-6 
SIRT1, IC50: 21 μM
SIRT2, IC50: 10 μM
SIRT3, IC50: 67 μM
   98.33%
Perindopril erbumine   
SIRT3
   99.98%
Inauhzin 
SIRT1
     99.49%
SRT 2183 
SIRT1, EC1.5: 0.36 μM
     98.06%
Tenovin-1
Sirtuin
      99.88%
Scopolin 
SIRT1
     99.93%
SIRT1-IN-1 
SIRT1, IC50: 0.205 μM
SIRT2, IC50: 11.5 μM
SIRT3, IC50: >100 μM
   98.19%
CAY10602 
SIRT1
     98.65%
Perindopril   
SIRT3
   98.11%
SIRT5 inhibitor 3     
SIRT5, IC50: 5.9 μM
 ≥98.0%
Et-29     
SIRT5, Ki: 40 nM
 99.89%
Salermide 
SIRT1
SIRT2
    ≥98.0%
SIRT-IN-2 
SIRT1, IC50: 4 nM
SIRT2, IC50: 1 nM
SIRT3, IC50: 7 nM
   98.08%
Dihydrocoumarin 
hSIRT1, IC50: 208 μM
hSIRT2, IC50: 295 μM
    99.81%
PROTAC Sirt2 Degrader-1  
SIRT2, IC50: 0.25 μM
    98.71%
E1231 
SIRT1, EC50: 0.83 μM
     98.55%
SIRT1-IN-2 
SIRT1, IC50: 1.6 μM
SIRT2, IC50: 39 μM
    98.86%
Tenovin-6 Hydrochloride 
SIRT1, IC50: 21 μM
SIRT2, IC50: 10 μM
SIRT3, IC50: 67 μM
   98.88%
Segetalin B 
SIRT1
     99.51%
Nicotinamide (Standard)  
SIRT2
    99.85%
5-Heptadecylresorcinol   
SIRT3
   99.83%
AK-1  
SIRT2, IC50: 12.5 μM
    99.97%
Gardenia yellow   
SIRT3
   
Sirtuin-1 inhibitor 1 
SIRT1
     98.09%
SIRT-IN-1 
SIRT1, IC50: 15 nM
SIRT2, IC50: 10 nM
SIRT3, IC50: 33 nM
   98.14%
(S)-Selisistat 
SIRT1, IC50: 98 nM
     99.39%
SIRT2-IN-8  
SIRT2
    99.32%
YK-3-237 
SIRT1
     99.54%
SIRT3 activator 2   
SIRT3
   98.94%
Lumbokinase 
SIRT1
     
SIRT2-IN-9 
SIRT1, IC50: >300 μM
SIRT2, IC50: 1.3 μM
SIRT3, IC50: >300 μM
   99.45%
SIRT1-IN-3 
SIRT1, IC50: 4.2 μM
SIRT2, IC50: 38 μM
    99.18%
Sirt2-IN-1  
SIRT2, IC50: 163 nM
    98.71%
Tanshindiol C 
SIRT1
     98.47%
Suramin 
SIRT1, IC50: 297 nM
SIRT2, IC50: 1.15 μM
  
SIRT5, IC50: 22 μM
 
SIRT2-IN-11 
SIRT1, IC50: 118.4 μM
SIRT2, IC50: 18.5 μM
    99.94%
RK-9123016  
SIRT2, IC50: 0.18 μM
    99.02%
JGB1741 
SIRT1, IC50: ∼15 μM
SIRT2, IC50: >100 μM
SIRT3, IC50: >100 μM
   99.05%
SIRT6-IN-3 
SIRT1, IC50: 80.52 μM
SIRT2, IC50: 92.21 μM
 
SIRT6, IC50: 7.46 μM
  98.19%
AC-93253 
SIRT1, IC50: 45.3 μM
SIRT2, IC50: 6 μM
SIRT3, IC50: 24.6 μM
   
MIND4-19  
SIRT2, IC50: 7.0 μM
    99.93%
Sirtuin modulator 1 
SIRT1, EC1.5: 1 μM
     99.85%
Ophiopogonin D' 
SIRT1
     99.85%
CrBKA    
SIRT6
  98.46%
Nicotinamide riboside 
SIRT1
 
SIRT3
   
CHIC35 
SIRT1, IC50: 0.124 μM
SIRT2, IC50: 2.8 μM
SIRT3, IC50: >100 μM
   
SIRT1/2/3-IN-2 
SIRT1
SIRT2
SIRT3
   
Sirt2-IN-5  
SIRT2
    
SPC-180002 
SIRT1, IC50: 1.13 ± 0.3 μM
 
SIRT3, IC50: 5.41 ± 4.8 μM
   
Epigenetic factor-IN-1      
SIRT7
3β,6α,12β-Dammar-E-20(22)-ene-3,6,12,25-tetraol 
SIRT1
     
SirReal-1  
SIRT2, IC50: 3.7 μM
    
Sirt2-IN-6  
SIRT2, IC50: 0.815 μM
    
Nicotinamide Hydrochloride 
SIRT1, IC50: 50-180 μM
SIRT2, EC50: 2 μM
    
hsa62 
SIRT1, IC50: 1.3 μM
SIRT2, IC50: 5.5 μM
SIRT3, IC50: 43.6 μM
   
DCHC 
SIRT1
     
C1A   
SIRT3, IC50: 55 μM
   
SIRT5 inhibitor 5     
SIRT5, IC50: 0.21 μM
 
SIRT5 inhibitor 4 
SIRT1, IC50: >400 μM
SIRT2, IC50: >400 μM
SIRT3, IC50: >400 μM
SIRT6, IC50: >400 μM
SIRT5, IC50: 26.4 μM
SIRT7, IC50: >400 μM
Nicotinamide riboside tartrate 
SIRT1
 
SIRT3
   
SIRT6 activator 2    
SIRT6
  
Sirt1/2-IN-1 
SIRT1, IC50: 1.81 μg/mL
SIRT2, IC50: 2.10 μg/mL
SIRT3, IC50: 20.5 μg/mL
   
Sirtuin modulator 4 
SIRT1, EC50: 51-100 μM
     
SIRT1-IN-5 
SIRT1
     
SIRT2-IN-14 
SIRT1, IC50: >200 μM
SIRT2, IC50: 0.196 μM
SIRT3, IC50: 85.8 μM
   
Nicotinamide riboside malate 
SIRT1
 
SIRT3
   
SIRT5 inhibitor 2     
SIRT5, IC50: 2.3 μM
 
Sirtuin modulator 5 
SIRT1, DC50: <50 μM
     
Sirtuin-IN-2     
SIRT5
 
SR94  
SIRT2
    
HSP70/SIRT2-IN-1  
SIRT2, IC50: 17.3±2.0 μM
    
SIRT3-IN-1   
SIRT3, IC50: 0.043 μM
   
FLS-359  
SIRT2, IC50: 3 μM
    
SIRT6-IN-4 
SIRT1, IC50: 311.9 μM
SIRT2, IC50: 157.2 μM
SIRT3, IC50: 274.1 μM
SIRT6, IC50: 5.86 μM
  
YZL-51N      
SIRT7, IC50: 12.71 μM
Cudraflavone B 
SIRT1
     
ZINC08792229 
SIRT1
     
SIRT3-IN-2   
SIRT3
   
A2B57  
SIRT2, IC50: 6.3 μM
    
SIRT-IN-6 
SIRT1, IC50: >50 μM
SIRT2, IC50: >50 μM
SIRT3, IC50: >50 μM
   
A1B11  
SIRT2, IC50: 5.3 μM